SpectraCure AB · FWB:2OK

SpectraCure AB financial statements

SpectraCure AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue868.0K19.5M318.0K539.0K5.75M1.21K763596.0K259.0K172.9K
Cost of revenue30.1M9.77M9.54M-3.05M-1.39M-2.35M-2.62M-2.13M-1.55M-1.14M
Gross profit-30.1M9.77M-9.22M3.58M1.39M2.35M2.62M2.72M1.81M1.31M
Selling, general and administrative13.4M12.3M12.7M11.6M10.7M8.32M7.82M6.55M5.93M5.21M
Operating income-54.4M-24.5M-21.4M-27.0M-24.4M-16.5M-14.3M-9.62M-8.70M-6.82M
Depreciation and amortization2.55M2.63M2.66M2.93M2.67M2.28M2.12M150.0K1.17M136.8K
EBITDA-51.8M-21.9M-18.7M-24.0M-21.8M-14.2M-12.2M-9.47M-7.53M-6.68M
Interest expense1.25M468.0K522.0K182.0K245.0K276.0K224.0K06443.5K
Income before tax-56.1M-23.0M-20.5M-25.4M-23.3M-15.4M-13.7M-9.61M-8.70M-6.37M
Income tax27.0K-7.00K-21.0K-53.0K-5.00K-30.0K-7.00K167.0K51550
Net income-56.1M-23.0M-20.4M-25.3M-23.3M-15.4M-13.7M-9.61M-8.70M-6.37M
Earnings per share, basic-0.14-0.24-0.21-0.26-0.24-0.17-0.16-0.12-0.15-0.21

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents13.5M18.3M57.0M93.2M129.7M157.2M54.2M45.1M2.44M381.7K
Receivables2.21M3.62M183.0K1.10M1.08M872.0K842.0K1.80M249.5K19.6M
Inventory10-100-13.0K-4.40K-19.2M
Current assets16.2M22.2M58.7M94.3M130.8M158.4M56.8M47.5M2.91M20.0M
Property, plant and equipment3.05M5.40M6.95M3.96M6.18M6.71M7.99M132.0K193.7K121.1K
Total assets104.5M121.0M144.8M162.4M190.5M210.5M100.2M68.9M14.7M28.8M
Accounts payable1.71M3.32M1.04M1.61M1.83M59.0K1.75M1.56M391.7K3.04M
Current liabilities10.7M11.5M10.6M11.8M12.4M9.86M7.55M4.03M1.30M6.66M
Total debt3.01M5.14M6.72M2.70M4.90M5.36M6.71M
Total liabilities10.9M14.1M15.0M12.1M14.8M13.3M12.4M4.03M1.30M6.66M
Shareholders' equity93.5M106.9M129.9M150.3M175.7M197.2M87.8M64.9M13.4M22.1M
Shares outstanding409.7M97.1M97.1M97.1M97.1M92.4M83.1M78.4M57.1M30.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-24.0M-21.8M-18.7M-23.0M-18.6M-9.40M-10.1M-8.97M6.33M-19.6M
Capital spending-19.6M-15.3M-15.8M-10.1M-8.49M-10.6M-15.1M-9.39M-4.27M-3.80M
Free cash flow-43.7M-37.1M-34.4M-33.1M-27.1M-20.0M-25.2M-18.4M2.06M-23.4M
Cash from investing-19.6M-15.3M-15.6M-11.3M-8.49M-10.6M-15.1M-9.39M-4.27M-3.62M
Cash from financing38.9M-1.57M-1.99M-2.20M-453.0K123.0M34.3M50.6M67.5M15.4M
Share buybacks54.8M0139.9M37.9M57.6M015.4M
Change in cash-4.75M-38.7M-36.2M-36.5M-27.5M103.0M9.13M32.2M2.06M-7.79M